Listening for Needs, Delivering Solutions
Dublin, Ireland
Mallinckrodt Pharmaceuticals combined with Endo in 2025 to better serve customers and improve outcomes for the patients we support. From this union, we established two focused, standalone companies: – Keenova Therapeutics, a branded therapeutics business – Par Health, a generics and sterile injectables business To learn more, follow Keenova and Par Health on LinkedIn and visit keenova.com and parhealth.com.
Télétravail · Quebec, Canada
Lead commercial efforts for inhaled nitric oxide therapy across Eastern Canada by driving revenue targets and uncovering growth opportunities. Provide therapeutic education to healthcare professionals and manage device maintenance schedules in partnership with technical teams.